Celebrex Adverse Events On FDA Pediatrics Committee Agenda In Late March
This article was originally published in The Pink Sheet Daily
Executive Summary
Celebrex adverse events will be reviewed by FDA Pediatrics Advisory Committee March 25; seven other drugs also on agenda.